Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53
Lucy Dorrell
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
MRC Laboratories, Fajara, The Gambia
Search for more papers by this authorBenjamin E. Willcox
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorE. Yvonne Jones
Division of Structural Biology, Wellcome Trust Centre for Human Genetics, Oxford, GB
Search for more papers by this authorGerry Gillespie
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorKati DeGleria
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorTim Rostron
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorEric Lepin
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorAndrew McMichael
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorCorresponding Author
Sarah Rowland-Jones
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, GB Fax: + 44-1865-222502Search for more papers by this authorLucy Dorrell
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
MRC Laboratories, Fajara, The Gambia
Search for more papers by this authorBenjamin E. Willcox
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorE. Yvonne Jones
Division of Structural Biology, Wellcome Trust Centre for Human Genetics, Oxford, GB
Search for more papers by this authorGerry Gillespie
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorKati DeGleria
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorTim Rostron
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorEric Lepin
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorAndrew McMichael
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
Search for more papers by this authorCorresponding Author
Sarah Rowland-Jones
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, GB Fax: + 44-1865-222502Search for more papers by this author